BLEOMYCIN SULFATE

BLEOMYCIN SULFATE was reported 10369 times

BLEOMYCIN SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GROWING TERATOMA SYNDROME 25 0.7576
1 ABNORMAL DNA METHYLATION 5 0.6250
2 FLAGELLATE DERMATITIS 30 0.4615
3 OVARIAN GERM CELL TERATOMA 32 0.4000
4 NECROTISING GASTRITIS 12 0.3750
5 BASAL GANGLION DEGENERATION 34 0.3617
6 TERATOMA BENIGN 19 0.3519
7 HODGKIN'S DISEASE RECURRENT 8 0.3333
8 TERATOMA 46 0.2140
9 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT 8 0.1739
10 TAENIASIS 7 0.1667
11 PLEUROPARENCHYMAL FIBROELASTOSIS 16 0.1538
12 MUCOEPIDERMOID CARCINOMA OF SALIVARY GLAND 9 0.1525
13 CHORIOCARCINOMA 11 0.1392
14 HODGKIN'S DISEASE NODULAR SCLEROSIS STAGE UNSPECIFIED 5 0.1316
15 PNEUMONIA SALMONELLA 6 0.1277
16 TISSUE INFILTRATION 35 0.1186
17 AZOOSPERMIA 44 0.1146
18 VASCULAR ACCESS SITE OCCLUSION 9 0.1139
19 NAIL BED INFLAMMATION 35 0.1097
20 ASTHENOSPERMIA 7 0.1077
21 SPERMATOGENESIS ABNORMAL 9 0.1071
22 SYNOVIAL SARCOMA 10 0.1053
23 TESTICULAR CANCER METASTATIC 9 0.1047
24 MENINGOENCEPHALITIS AMOEBIC 6 0.1034
25 ENDOCARDITIS NONINFECTIVE 15 0.1007
26 PRIMARY IMMUNODEFICIENCY SYNDROME 8 0.0988
27 TULARAEMIA 9 0.0928
28 TREATMENT RELATED SECONDARY MALIGNANCY 16 0.0788
29 LEUKOPENIA NEONATAL 5 0.0758
30 ANAESTHESIA 26 0.0712
31 NEUTROPENIC INFECTION 67 0.0700
32 ACUTE MYELOMONOCYTIC LEUKAEMIA 16 0.0635
33 CHLOROMA 26 0.0616
34 CUTANEOUS CALCIFICATION 11 0.0601
35 NASAL MUCOSAL DISORDER 35 0.0600
36 PULMONARY TOXICITY 417 0.0589
37 COMBINED IMMUNODEFICIENCY 9 0.0559
38 AUTOIMMUNE PANCYTOPENIA 5 0.0549
39 CARBON MONOXIDE DIFFUSING CAPACITY DECREASED 9 0.0529
40 ASPLENIA 5 0.0505
41 REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA 5 0.0490
42 SPINDLE CELL SARCOMA 6 0.0441
43 UTERINE ENLARGEMENT 35 0.0441
44 ACANTHAMOEBA INFECTION 8 0.0426
45 OOPHORITIS 6 0.0423
46 OROPHARYNGEAL SQUAMOUS CELL CARCINOMA 6 0.0417
47 STREPTOCOCCAL SEPSIS 48 0.0405
48 TOOTH MALFORMATION 7 0.0405
49 HODGKIN'S DISEASE 29 0.0400
50 AUTOIMMUNE NEUTROPENIA 11 0.0381
51 DIAPHRAGM MUSCLE WEAKNESS 6 0.0380
52 ABDOMINAL COMPARTMENT SYNDROME 24 0.0377
53 THYMUS ENLARGEMENT 6 0.0375
54 HIGH-GRADE B-CELL LYMPHOMA 7 0.0374
55 LIPOMATOSIS 7 0.0354
56 HEPATITIS B REACTIVATION 107 0.0337
57 INCLUSION BODY MYOSITIS 5 0.0333
58 PSYCHOGENIC SEIZURE 31 0.0332
59 HYPOCHROMIC ANAEMIA 32 0.0316
60 VOCAL CORD INFLAMMATION 9 0.0305
61 SECOND PRIMARY MALIGNANCY 241 0.0289
62 NAIL PIGMENTATION 7 0.0289
63 ACUTE PROMYELOCYTIC LEUKAEMIA 29 0.0282
64 PNEUMOMEDIASTINUM 51 0.0282
65 REFRACTORY CANCER 6 0.0280
66 PSEUDOMONAL SEPSIS 48 0.0274
67 PREMATURE AGEING 8 0.0272
68 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 6 0.0261
69 VULVOVAGINAL INFLAMMATION 12 0.0260
70 EPIPHYSIOLYSIS 6 0.0241
71 BLOOD HUMAN CHORIONIC GONADOTROPIN INCREASED 5 0.0235
72 SUBCUTANEOUS EMPHYSEMA 23 0.0234
73 OSTEOSARCOMA 9 0.0234
74 BLOOD STEM CELL TRANSPLANT FAILURE 5 0.0233
75 B PRECURSOR TYPE ACUTE LEUKAEMIA 9 0.0232
76 LISTERIA SEPSIS 6 0.0227
77 MALIGNANT TRANSFORMATION 10 0.0223
78 LYMPHOMA TRANSFORMATION 8 0.0222
79 TRAUMATIC LUNG INJURY 42 0.0217
80 BONE MARROW NECROSIS 5 0.0214
81 CEREBRAL ARTERY STENOSIS 10 0.0205
82 RENAL SALT-WASTING SYNDROME 8 0.0204
83 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 12 0.0202
84 PNEUMONITIS CHEMICAL 7 0.0201
85 CAROTID ARTERY THROMBOSIS 17 0.0200
86 ACUTE MYELOID LEUKAEMIA 305 0.0196
87 OESOPHAGEAL PERFORATION 16 0.0192
88 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 6 0.0192
89 BETA 2 MICROGLOBULIN INCREASED 5 0.0192
90 PATERNAL EXPOSURE TIMING UNSPECIFIED 5 0.0187
91 PNEUMOCYSTIS JIROVECI INFECTION 5 0.0181
92 CEREBRAL ARTERY THROMBOSIS 9 0.0175
93 BONE MARROW TOXICITY 20 0.0169
94 DILATED CARDIOMYOPATHY 17 0.0168
95 VASOGENIC CEREBRAL OEDEMA 12 0.0167
96 ENTEROBACTER BACTERAEMIA 5 0.0165
97 HERPES SIMPLEX REACTIVATION 6 0.0157
98 INVASIVE LOBULAR BREAST CARCINOMA 8 0.0156
99 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 6 0.0153
100 CELLULITE 5 0.0153
101 GASTROENTERITIS BACTERIAL 5 0.0152
102 VENA CAVA THROMBOSIS 25 0.0150
103 TESTICULAR DISORDER 15 0.0149
104 CYTOMEGALOVIRUS CHORIORETINITIS 29 0.0149
105 PNEUMOCYSTIS JIROVECI PNEUMONIA 33 0.0148
106 CATARACT SUBCAPSULAR 9 0.0148
107 MYELITIS 22 0.0142
108 MENINGITIS PNEUMOCOCCAL 5 0.0137
109 NEONATAL HYPOTENSION 5 0.0136
110 BRONCHOPNEUMOPATHY 5 0.0136
111 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 8 0.0135
112 ACUTE INTERSTITIAL PNEUMONITIS 7 0.0134
113 NEUROLOGICAL DECOMPENSATION 31 0.0134
114 PAPILLARY THYROID CANCER 23 0.0132
115 MEDIASTINAL MASS 5 0.0131
116 PREMATURE MENOPAUSE 12 0.0130
117 ISCHAEMIC CEREBRAL INFARCTION 15 0.0129
118 B-CELL LYMPHOMA RECURRENT 7 0.0129
119 PERIPHERAL SENSORIMOTOR NEUROPATHY 16 0.0127
120 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 28 0.0127
121 MYELODYSPLASTIC SYNDROME 182 0.0126
122 PERIPHERAL NERVE INJURY 11 0.0125
123 LUNG DIFFUSION TEST DECREASED 5 0.0125
124 SUPERIOR SAGITTAL SINUS THROMBOSIS 10 0.0125
125 PERIPHERAL SENSORY NEUROPATHY 73 0.0125
126 FEBRILE NEUTROPENIA 828 0.0125
127 ANAEMIA NEONATAL 6 0.0124
128 ARTERIAL THROMBOSIS 24 0.0124
129 NON-HODGKIN'S LYMPHOMA 16 0.0122
130 CEREBRAL VENOUS THROMBOSIS 22 0.0121
131 HAEMATOTOXICITY 114 0.0120
132 RETROPERITONEAL FIBROSIS 7 0.0120
133 KAPOSI'S SARCOMA 6 0.0120
134 CORONARY ARTERY THROMBOSIS 24 0.0119
135 PERICARDITIS CONSTRICTIVE 5 0.0118
136 LEFT VENTRICULAR DILATATION 6 0.0117
137 CAROTID ARTERY DISSECTION 5 0.0117
138 EMBOLISM ARTERIAL 14 0.0116
139 KLEBSIELLA SEPSIS 13 0.0115
140 PEPTIC ULCER HAEMORRHAGE 8 0.0115
141 DYSAESTHESIA 35 0.0114
142 RETROPERITONEAL LYMPHADENOPATHY 6 0.0114
143 AORTIC THROMBOSIS 13 0.0112
144 GLOMERULOSCLEROSIS 7 0.0111
145 ACUTE LUNG INJURY 13 0.0110
146 KLEBSIELLA INFECTION 55 0.0109
147 CARDIOTOXICITY 97 0.0109
148 PRETERM PREMATURE RUPTURE OF MEMBRANES 13 0.0108
149 OTOTOXICITY 20 0.0108
150 PERIPHERAL MOTOR NEUROPATHY 15 0.0107
151 ADRENAL SUPPRESSION 9 0.0107
152 PERIPHERAL ARTERY THROMBOSIS 15 0.0107
153 PARAPARESIS 19 0.0107
154 FEBRILE BONE MARROW APLASIA 45 0.0106
155 STEM CELL TRANSPLANT 26 0.0104
156 HYPERBILIRUBINAEMIA NEONATAL 6 0.0103
157 VASCULAR DEVICE INFECTION 46 0.0101
158 THALAMIC INFARCTION 6 0.0101
159 STREPTOCOCCAL BACTERAEMIA 11 0.0101
160 PNEUMOCYSTIS JIROVECII INFECTION 12 0.0100
161 MYELOID LEUKAEMIA 5 0.0100
162 PULMONARY FIBROSIS 189 0.0098
163 NEUTROPENIC SEPSIS 70 0.0098
164 DEMYELINATING POLYNEUROPATHY 10 0.0097
165 NEUTROPENIC COLITIS 20 0.0097
166 ACUTE LYMPHOCYTIC LEUKAEMIA 27 0.0095
167 HYPERPYREXIA 40 0.0094
168 ACUTE RESPIRATORY DISTRESS SYNDROME 167 0.0094
169 INTRACRANIAL VENOUS SINUS THROMBOSIS 10 0.0093
170 CEREBRAL ARTERY OCCLUSION 10 0.0093
171 MEASLES 5 0.0093
172 SARCOIDOSIS 44 0.0093
173 VENOOCCLUSIVE DISEASE 23 0.0092
174 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 12 0.0091
175 VANISHING BILE DUCT SYNDROME 10 0.0090
176 ACUTE HEPATIC FAILURE 122 0.0089
177 COMPUTERISED TOMOGRAM THORAX ABNORMAL 6 0.0087
178 DIFFUSE ALVEOLAR DAMAGE 10 0.0087
179 APLASIA 17 0.0087
180 ACUTE LEUKAEMIA 14 0.0087
181 ALPHA 1 FOETOPROTEIN INCREASED 6 0.0084
182 LYMPHATIC DISORDER 5 0.0084
183 METASTASES TO LYMPH NODES 56 0.0083
184 MUCOSAL INFLAMMATION 217 0.0083
185 METASTASIS 59 0.0083
186 ENCEPHALITIS VIRAL 10 0.0082
187 PARONYCHIA 36 0.0082
188 CHRONIC MYELOID LEUKAEMIA 37 0.0080
189 LYMPHOCYTIC INFILTRATION 8 0.0079
190 DRUG EXPOSURE BEFORE PREGNANCY 8 0.0079
191 NEUROPSYCHIATRIC SYMPTOMS 7 0.0078
192 HISTIOCYTOSIS HAEMATOPHAGIC 23 0.0077
193 RESTRICTIVE PULMONARY DISEASE 9 0.0077
194 C-REACTIVE PROTEIN DECREASED 5 0.0077
195 PNEUMONITIS 206 0.0076
196 INTERVERTEBRAL DISC DISORDER 32 0.0075
197 SPLENIC INFARCTION 13 0.0074
198 PARANEOPLASTIC SYNDROME 5 0.0074
199 PNEUMOCYSTIS JIROVECII PNEUMONIA 74 0.0074
200 MONOPLEGIA 32 0.0074
201 BONE MARROW DEPRESSION 7 0.0072
202 SUBCLAVIAN VEIN THROMBOSIS 8 0.0070
203 CORONARY ARTERY DISSECTION 6 0.0070
204 T-CELL LYMPHOMA 8 0.0070
205 VARICOSE VEIN 36 0.0070
206 SUBDURAL HAEMORRHAGE 19 0.0069
207 B-CELL TYPE ACUTE LEUKAEMIA 5 0.0068
208 ESCHERICHIA BACTERAEMIA 16 0.0068
209 QUADRIPLEGIA 14 0.0068
210 LUNG INFILTRATION 60 0.0068
211 COMA HEPATIC 5 0.0067
212 MYCOBACTERIUM AVIUM COMPLEX INFECTION 18 0.0067
213 PAPILLOMA VIRAL INFECTION 11 0.0067
214 DISSEMINATED CRYPTOCOCCOSIS 5 0.0066
215 BRAIN OEDEMA 82 0.0065
216 CANDIDA INFECTION 109 0.0064
217 ABDOMINAL TENDERNESS 32 0.0064
218 PULMONARY MYCOSIS 5 0.0064
219 PULMONARY FUNCTION TEST ABNORMAL 10 0.0064
220 TUMOUR LYSIS SYNDROME 56 0.0064
221 BONE MARROW FAILURE 128 0.0063
222 BARRETT'S OESOPHAGUS 5 0.0062
223 CYTOGENETIC ABNORMALITY 7 0.0062
224 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 5 0.0062
225 OPTIC ATROPHY 10 0.0061
226 BACTERIAL SEPSIS 20 0.0061
227 VOCAL CORD PARALYSIS 11 0.0061
228 ASPERGILLOSIS 8 0.0061
229 SCLERODERMA 22 0.0060
230 RESPIRATORY SYMPTOM 17 0.0060
231 FOETAL GROWTH RESTRICTION 36 0.0059
232 CAPILLARY LEAK SYNDROME 12 0.0058
233 CONGESTIVE CARDIOMYOPATHY 24 0.0058
234 INGUINAL HERNIA 35 0.0057
235 OLIGOHYDRAMNIOS 19 0.0057
236 INTESTINAL PSEUDO-OBSTRUCTION 5 0.0057
237 VENOOCCLUSIVE LIVER DISEASE 28 0.0057
238 ORGANISING PNEUMONIA 28 0.0056
239 CARDIAC DYSFUNCTION 21 0.0056
240 HYPERPLASIA 5 0.0056
241 LEFT VENTRICULAR DYSFUNCTION 37 0.0055
242 MICROCEPHALY 7 0.0055
243 HYPERVENTILATION 31 0.0053
244 ACQUIRED GENE MUTATION 7 0.0053
245 AREFLEXIA 14 0.0052
246 ACTINOMYCOSIS 5 0.0052
247 SYSTEMIC CANDIDA 13 0.0052
248 HAEMOLYTIC URAEMIC SYNDROME 12 0.0052
249 GUILLAIN-BARRE SYNDROME 25 0.0052
250 IDIOSYNCRATIC DRUG REACTION 5 0.0051
251 SINUS ARREST 8 0.0051
252 NEOPLASM RECURRENCE 17 0.0050
253 VENTRICULAR HYPOKINESIA 16 0.0050
254 AORTIC VALVE DISEASE 8 0.0050
255 CLOSTRIDIUM COLITIS 6 0.0049
256 SECONDARY IMMUNODEFICIENCY 6 0.0049
257 AUTONOMIC NEUROPATHY 5 0.0049
258 CRYPTOCOCCOSIS 8 0.0049
259 INTERSTITIAL LUNG DISEASE 234 0.0048
260 HEPATITIS B 29 0.0048
261 RENAL ATROPHY 6 0.0048
262 METASTASES TO CENTRAL NERVOUS SYSTEM 62 0.0048
263 RENAL CYST 38 0.0048
264 NORMOCYTIC ANAEMIA 7 0.0048
265 OSTEOPOROTIC FRACTURE 9 0.0047
266 BLOOD BILIRUBIN ABNORMAL 6 0.0047
267 PNEUMOTHORAX 74 0.0047
268 PNEUMONIA CYTOMEGALOVIRAL 9 0.0046
269 GRANULOMA 16 0.0046
270 EXPOSURE VIA FATHER 6 0.0046
271 NEUTROPHIL COUNT ABNORMAL 13 0.0046
272 MENINGITIS CRYPTOCOCCAL 8 0.0046
273 FIBROSIS 14 0.0045
274 MITRAL VALVE DISEASE 8 0.0045
275 EPSTEIN-BARR VIRAEMIA 5 0.0045
276 LARYNGEAL CANCER 5 0.0045
277 POSTPARTUM HAEMORRHAGE 6 0.0045
278 NEUTROPENIA 605 0.0044
279 FUNGAEMIA 7 0.0044
280 LYMPHOCYTE COUNT ABNORMAL 5 0.0044
281 RESPIRATORY FAILURE 322 0.0044
282 THERAPY PARTIAL RESPONDER 68 0.0044
283 VARICELLA ZOSTER VIRUS INFECTION 9 0.0043
284 VIRAEMIA 6 0.0043
285 LIP ULCERATION 5 0.0043
286 NEUROTOXICITY 75 0.0043
287 ALVEOLITIS 6 0.0042
288 PELVIC VENOUS THROMBOSIS 6 0.0042
289 MYOSITIS 37 0.0041
290 PHARYNGEAL INFLAMMATION 5 0.0041
291 LYMPHOPROLIFERATIVE DISORDER 12 0.0041
292 AUTOIMMUNE HAEMOLYTIC ANAEMIA 14 0.0041
293 EMPYEMA 8 0.0040
294 DIFFUSE LARGE B-CELL LYMPHOMA 31 0.0040
295 INFERTILITY 6 0.0040
296 SMALL CELL LUNG CANCER 6 0.0040
297 PANCYTOPENIA 217 0.0039
298 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 32 0.0039
299 ATRIAL THROMBOSIS 8 0.0039
300 EPSTEIN-BARR VIRUS INFECTION 24 0.0038
301 SEPTIC SHOCK 162 0.0037
302 LEUKAEMIA 35 0.0037
303 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 35 0.0037
304 LYMPHADENOPATHY MEDIASTINAL 7 0.0037
305 SPLENIC RUPTURE 6 0.0036
306 BONE MARROW DISORDER 11 0.0036
307 APLASTIC ANAEMIA 19 0.0036
308 SPLENOMEGALY 42 0.0036
309 MENINGITIS ASEPTIC 16 0.0036
310 MULTIPLE-DRUG RESISTANCE 11 0.0035
311 SKIN TOXICITY 20 0.0035
312 IMMUNE THROMBOCYTOPENIC PURPURA 10 0.0035
313 APHTHOUS STOMATITIS 8 0.0035
314 HYPERAMMONAEMIC ENCEPHALOPATHY 6 0.0034
315 CARDIOMYOPATHY 51 0.0034
316 EXTREMITY NECROSIS 6 0.0034
317 PULMONARY SEPSIS 5 0.0034
318 PULMONARY FUNCTION TEST DECREASED 15 0.0034
319 POLYNEUROPATHY 41 0.0034
320 DEAFNESS 88 0.0034
321 DILATATION VENTRICULAR 7 0.0033
322 LUNG ADENOCARCINOMA 10 0.0033
323 LEUKOPENIA 165 0.0033
324 RADIATION PNEUMONITIS 7 0.0033
325 NEURITIS 5 0.0032
326 BLOOD LACTIC ACID INCREASED 17 0.0032
327 NEOPLASM SKIN 5 0.0032
328 RENAL TUBULAR DISORDER 9 0.0032
329 STENOSIS 6 0.0032
330 THROMBOCYTOPENIA 356 0.0032
331 EOSINOPHILIC PNEUMONIA 10 0.0032
332 PLATELET DISORDER 8 0.0032
333 HEPATITIS E 5 0.0032
334 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 12 0.0031
335 JC VIRUS INFECTION 5 0.0031
336 CUSHINGOID 10 0.0031
337 LYMPHOPENIA 44 0.0031
338 BRONCHOPULMONARY ASPERGILLOSIS 24 0.0031
339 RED BLOOD CELL SEDIMENTATION RATE INCREASED 34 0.0031
340 PULMONARY HAEMORRHAGE 24 0.0031
341 LUNG OPACITY 8 0.0030
342 PULMONARY CONGESTION 40 0.0030
343 EMBOLISM 25 0.0030
344 BACTERIAL INFECTION 56 0.0030
345 B-CELL LYMPHOMA 10 0.0029
346 CYTOPENIA 36 0.0029
347 NEPHROPATHY TOXIC 33 0.0029
348 HYPOVOLAEMIC SHOCK 14 0.0029
349 PREMATURE RUPTURE OF MEMBRANES 7 0.0029
350 SPINAL PAIN 34 0.0029
351 PREMATURE BABY 87 0.0029
352 SEPSIS 321 0.0029
353 HYPOPITUITARISM 5 0.0029
354 LIVEDO RETICULARIS 6 0.0029
355 LUNG CONSOLIDATION 8 0.0029
356 MUSCLE SPASTICITY 35 0.0028
357 PREMATURE LABOUR 16 0.0028
358 CYTOMEGALOVIRUS INFECTION 47 0.0028
359 HEART DISEASE CONGENITAL 10 0.0028
360 NEONATAL RESPIRATORY DISTRESS SYNDROME 10 0.0028
361 ILEAL STENOSIS 5 0.0028
362 CYTOMEGALOVIRUS TEST POSITIVE 5 0.0028
363 LYMPHOCYTOSIS 6 0.0028
364 PARAPLEGIA 8 0.0028
365 THROMBOTIC MICROANGIOPATHY 27 0.0028
366 LYMPHADENOPATHY 98 0.0028
367 MONOPARESIS 5 0.0028
368 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
369 HYPOTHYROIDISM 88 0.0028
370 EJECTION FRACTION DECREASED 42 0.0027
371 RECURRENT CANCER 11 0.0027
372 ISCHAEMIC STROKE 48 0.0027
373 EXTRAVASATION 11 0.0027
374 ACUTE MYOCARDIAL INFARCTION 78 0.0026
375 DRUG TOXICITY 36 0.0026
376 CLOSTRIDIUM DIFFICILE COLITIS 28 0.0026
377 BONE MARROW TRANSPLANT 5 0.0026
378 GRANULOCYTOPENIA 15 0.0026
379 LUNG DISORDER 129 0.0026
380 BILIRUBIN CONJUGATED INCREASED 6 0.0026
381 CHRONIC LYMPHOCYTIC LEUKAEMIA 12 0.0025
382 DISEASE PROGRESSION 298 0.0025
383 TENDERNESS 26 0.0025
384 DEVICE RELATED SEPSIS 5 0.0025
385 HYPOKINESIA 36 0.0025
386 HYPOXIA 87 0.0025
387 OSTEONECROSIS 81 0.0025
388 ASPERGILLUS INFECTION 16 0.0024
389 HEPATOTOXICITY 54 0.0024
390 SMALL FOR DATES BABY 12 0.0024
391 HEMIPLEGIA 20 0.0024
392 IMMUNE THROMBOCYTOPENIA 11 0.0024
393 DISEASE RECURRENCE 114 0.0024
394 LOW BIRTH WEIGHT BABY 19 0.0024
395 OBESITY 38 0.0024
396 LUNG ABSCESS 5 0.0024
397 CEREBRAL INFARCTION 58 0.0024
398 NEOPLASM PROGRESSION 82 0.0024
399 TESTIS CANCER 9 0.0023
400 CERVICAL DYSPLASIA 5 0.0023
401 GASTROINTESTINAL TOXICITY 11 0.0023
402 ILEUS PARALYTIC 10 0.0022
403 PSEUDOMONAS INFECTION 19 0.0022
404 AGRANULOCYTOSIS 41 0.0022
405 PERIPHERAL ISCHAEMIA 9 0.0022
406 HYPERURICAEMIA 9 0.0022
407 ODYNOPHAGIA 13 0.0022
408 CYTOMEGALOVIRUS COLITIS 5 0.0022
409 ACUTE CORONARY SYNDROME 18 0.0022
410 LYMPHOEDEMA 15 0.0022
411 ENCEPHALITIS 15 0.0022
412 METASTASES TO LUNG 25 0.0022
413 IMMUNOSUPPRESSION 19 0.0022
414 ANGIOPATHY 12 0.0021
415 ENDOTRACHEAL INTUBATION 6 0.0021
416 RESPIRATORY DISORDER 64 0.0021
417 INTESTINAL PERFORATION 24 0.0021
418 BUNDLE BRANCH BLOCK LEFT 9 0.0021
419 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 7 0.0021
420 NEUROPATHY PERIPHERAL 201 0.0021
421 RETINAL HAEMORRHAGE 15 0.0021
422 PNEUMATOSIS INTESTINALIS 6 0.0021
423 DRUG RESISTANCE 54 0.0021
424 SUPRAVENTRICULAR EXTRASYSTOLES 7 0.0021
425 WOUND DEHISCENCE 7 0.0021
426 ESCHERICHIA SEPSIS 6 0.0021
427 RENAL TUBULAR NECROSIS 20 0.0020
428 VENOUS THROMBOSIS 8 0.0020
429 STAPHYLOCOCCAL SEPSIS 10 0.0020
430 HEPATITIS FULMINANT 6 0.0020
431 PLEURAL EFFUSION 122 0.0020
432 HYDRONEPHROSIS 15 0.0020
433 THROMBOPHLEBITIS 7 0.0020
434 HEPATIC STEATOSIS 37 0.0020
435 METASTASES TO PERITONEUM 5 0.0020
436 NECROSIS 11 0.0020
437 ACUTE RESPIRATORY FAILURE 38 0.0020
438 ISCHAEMIA 9 0.0020
439 NOCARDIOSIS 5 0.0020
440 SKIN FISSURES 38 0.0019
441 BRAIN DEATH 6 0.0019
442 HEPATIC ENCEPHALOPATHY 18 0.0019
443 MYELOSUPPRESSION 69 0.0019
444 NEUTROPHIL COUNT DECREASED 77 0.0019
445 ANAEMIA 360 0.0019
446 PREMATURE DELIVERY 30 0.0019
447 WHITE BLOOD CELL COUNT ABNORMAL 12 0.0019
448 AORTIC VALVE INCOMPETENCE 8 0.0019
449 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
450 HYPOVOLAEMIA 11 0.0019
451 CARDIAC FAILURE CHRONIC 8 0.0019
452 HAEMOGLOBIN ABNORMAL 12 0.0019
453 C-REACTIVE PROTEIN INCREASED 67 0.0018
454 CARDIOGENIC SHOCK 26 0.0018
455 PLEURITIC PAIN 5 0.0018
456 CYTOLYTIC HEPATITIS 6 0.0018
457 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 9 0.0018
458 PULMONARY EMBOLISM 171 0.0018
459 THERAPEUTIC AGENT TOXICITY 6 0.0018
460 HYPOMAGNESAEMIA 25 0.0018
461 CARDIOPULMONARY FAILURE 7 0.0018
462 MALIGNANT NEOPLASM PROGRESSION 183 0.0018
463 DEEP VEIN THROMBOSIS 116 0.0018
464 SLEEP APNOEA SYNDROME 34 0.0018
465 RESTLESSNESS 65 0.0018
466 CEREBRAL THROMBOSIS 5 0.0018
467 SUDDEN CARDIAC DEATH 6 0.0018
468 LEFT VENTRICULAR FAILURE 6 0.0017
469 COAGULOPATHY 29 0.0017
470 RESPIRATORY DISTRESS 48 0.0017
471 OESOPHAGITIS 19 0.0017
472 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 13 0.0017
473 GASTROINTESTINAL NECROSIS 5 0.0017
474 ILEUS 21 0.0017
475 MULTI-ORGAN FAILURE 29 0.0017
476 SUBARACHNOID HAEMORRHAGE 17 0.0017
477 GRAFT VERSUS HOST DISEASE 12 0.0017
478 MIXED LIVER INJURY 5 0.0017
479 NEUTROPHIL COUNT INCREASED 17 0.0017
480 CEREBROVASCULAR DISORDER 5 0.0017
481 STILLBIRTH 8 0.0017
482 MONOCYTE COUNT INCREASED 6 0.0017
483 MASS 23 0.0016
484 THROMBOCYTOSIS 6 0.0016
485 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
486 CHEST X-RAY ABNORMAL 5 0.0016
487 METASTATIC NEOPLASM 7 0.0016
488 SCOLIOSIS 10 0.0016
489 TOXICITY TO VARIOUS AGENTS 271 0.0016
490 PULMONARY ALVEOLAR HAEMORRHAGE 9 0.0016
491 CORONARY ARTERY STENOSIS 8 0.0016
492 FOETAL EXPOSURE DURING PREGNANCY 129 0.0016
493 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 8 0.0016
494 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
495 CAESAREAN SECTION 18 0.0015
496 EPIGASTRIC DISCOMFORT 6 0.0015
497 VIRAL INFECTION 51 0.0015
498 HEPATIC NEOPLASM 5 0.0015
499 ARTERIAL OCCLUSIVE DISEASE 12 0.0015
500 NAIL DISCOLOURATION 6 0.0015
501 PNEUMONIA FUNGAL 6 0.0015
502 DEAFNESS NEUROSENSORY 5 0.0015
503 DERMATITIS BULLOUS 11 0.0015
504 SKIN HYPERPIGMENTATION 13 0.0015
505 CARDIAC FAILURE ACUTE 10 0.0015
506 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
507 CYSTITIS HAEMORRHAGIC 6 0.0015
508 BONE PAIN 87 0.0015
509 BRONCHIECTASIS 10 0.0015
510 NEOPLASM 17 0.0015
511 CARDIAC TAMPONADE 7 0.0015
512 PRE-ECLAMPSIA 7 0.0015
513 PERICARDIAL EFFUSION 34 0.0015
514 HYDROCEPHALUS 8 0.0015
515 ESCHERICHIA INFECTION 12 0.0015
516 INTESTINAL ISCHAEMIA 8 0.0015
517 TROPONIN INCREASED 11 0.0014
518 HAIR GROWTH ABNORMAL 10 0.0014
519 HYPERTRANSAMINASAEMIA 10 0.0014
520 BACTERAEMIA 17 0.0014
521 EXPOSURE DURING PREGNANCY 89 0.0014
522 NECROTISING FASCIITIS 5 0.0014
523 HEMIPARESIS 24 0.0014
524 LUNG INFECTION 22 0.0014
525 FACIAL PARALYSIS 12 0.0014
526 HYPOTONIA 14 0.0014
527 TOXIC SKIN ERUPTION 14 0.0014
528 BLOOD LACTATE DEHYDROGENASE INCREASED 22 0.0014
529 HERPES SIMPLEX 9 0.0014
530 DERMATITIS 29 0.0014
531 CAROTID ARTERY OCCLUSION 5 0.0014
532 ASTHMATIC CRISIS 5 0.0014
533 ONYCHOMYCOSIS 6 0.0014
534 ORAL CANDIDIASIS 18 0.0014
535 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 14 0.0014
536 INFECTION 197 0.0014
537 PYREXIA 467 0.0013
538 DISSEMINATED INTRAVASCULAR COAGULATION 19 0.0013
539 SKIN NECROSIS 7 0.0013
540 SINUS BRADYCARDIA 13 0.0013
541 ENCEPHALOPATHY 33 0.0013
542 PAPILLOEDEMA 6 0.0013
543 HEPATITIS CHOLESTATIC 8 0.0013
544 HEPATIC FAILURE 40 0.0013
545 STOMATITIS 79 0.0013
546 PIGMENTATION DISORDER 8 0.0013
547 LYMPHOMA 20 0.0013
548 ARTHRITIS INFECTIVE 6 0.0013
549 HYPOALBUMINAEMIA 10 0.0013
550 PERFORMANCE STATUS DECREASED 6 0.0013
551 ENTERITIS 8 0.0012
552 BLOOD DISORDER 10 0.0012
553 C-REACTIVE PROTEIN ABNORMAL 8 0.0012
554 SENSORY DISTURBANCE 20 0.0012
555 ENTEROCOCCAL INFECTION 6 0.0012
556 TRANSFUSION 13 0.0012
557 MITRAL VALVE INCOMPETENCE 14 0.0012
558 NEUTROPHILIA 7 0.0012
559 HAEMOLYTIC ANAEMIA 11 0.0012
560 ARTHRITIS BACTERIAL 5 0.0012
561 HICCUPS 10 0.0012
562 STRESS CARDIOMYOPATHY 7 0.0012
563 PRODUCT USE IN UNAPPROVED INDICATION 297 0.0012
564 UROSEPSIS 11 0.0012
565 RENAL FAILURE ACUTE 50 0.0012
566 MATERNAL EXPOSURE BEFORE PREGNANCY 8 0.0012
567 DEVICE RELATED INFECTION 18 0.0012
568 TACHYCARDIA 103 0.0012
569 FOETAL DEATH 6 0.0012
570 HEPATIC LESION 5 0.0012
571 NO THERAPEUTIC RESPONSE 14 0.0011
572 CARDIAC FAILURE 92 0.0011
573 RIGHT VENTRICULAR FAILURE 8 0.0011
574 ABDOMINAL ABSCESS 5 0.0011
575 BLINDNESS 46 0.0011
576 HAEMATOMA 29 0.0011
577 CIRCULATORY COLLAPSE 19 0.0011
578 COLITIS 42 0.0011
579 ATRIAL SEPTAL DEFECT 9 0.0011
580 GASTRITIS EROSIVE 5 0.0011
581 BLOOD PRESSURE DECREASED 70 0.0011
582 PHARYNGITIS 13 0.0010
583 HERPES ZOSTER 60 0.0010
584 MYOPATHY 9 0.0010
585 HERPES VIRUS INFECTION 6 0.0010
586 HYPOKALAEMIA 48 0.0010
587 ENTEROCOLITIS 6 0.0010
588 ATELECTASIS 10 0.0010
589 HYPONATRAEMIA 58 0.0010
590 GROIN PAIN 9 0.0010
591 MULTIPLE ORGAN DYSFUNCTION SYNDROME 29 0.0010
592 MATERNAL EXPOSURE DURING PREGNANCY 90 0.0010
593 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 55 0.0010
594 BLOOD BILIRUBIN INCREASED 27 0.0010
595 TRANSAMINASES INCREASED 22 0.0010
596 DYSLIPIDAEMIA 5 0.0010
597 HYPERTHYROIDISM 14 0.0010
598 CYANOSIS 15 0.0010
599 PERICARDITIS 16 0.0010
600 CHILLS 111 0.0009
601 HEPATIC CYTOLYSIS 12 0.0009
602 IMMUNODEFICIENCY 14 0.0009
603 DYSPHAGIA 89 0.0009
604 TINNITUS 43 0.0009
605 FUNGAL INFECTION 31 0.0009
606 GINGIVITIS 5 0.0009
607 PHARYNGITIS STREPTOCOCCAL 10 0.0009
608 BLINDNESS UNILATERAL 13 0.0009
609 OFF LABEL USE 803 0.0009
610 HYPERTHERMIA 7 0.0009
611 MATERNAL DRUGS AFFECTING FOETUS 7 0.0009
612 AMENORRHOEA 16 0.0009
613 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 21 0.0009
614 APNOEA 7 0.0009
615 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
616 HYPOTHERMIA 9 0.0009
617 BODY TEMPERATURE INCREASED 18 0.0009
618 GENERAL PHYSICAL HEALTH DETERIORATION 102 0.0009
619 STAPHYLOCOCCAL INFECTION 29 0.0009
620 NEUROLOGICAL SYMPTOM 5 0.0009
621 CARDIAC VALVE DISEASE 5 0.0009
622 BLOOD URIC ACID INCREASED 5 0.0009
623 PULMONARY HYPERTENSION 18 0.0009
624 SUDDEN DEATH 9 0.0008
625 WHITE BLOOD CELL COUNT DECREASED 92 0.0008
626 DIALYSIS 12 0.0008
627 TREATMENT FAILURE 69 0.0008
628 DRUG-INDUCED LIVER INJURY 26 0.0008
629 PLATELET COUNT ABNORMAL 5 0.0008
630 MALIGNANT MELANOMA 11 0.0008
631 ORAL DISORDER 6 0.0008
632 LIVER INJURY 20 0.0008
633 HEPATOMEGALY 8 0.0008
634 INFLAMMATION 42 0.0008
635 ANURIA 7 0.0008
636 OBSTRUCTIVE AIRWAYS DISORDER 9 0.0008
637 PYELONEPHRITIS 7 0.0008
638 VOMITING 379 0.0008
639 OLIGURIA 5 0.0008
640 PNEUMONIA 260 0.0008
641 INTESTINAL OBSTRUCTION 30 0.0008
642 GRIP STRENGTH DECREASED 7 0.0008
643 PURPURA 7 0.0008
644 PHOTOPSIA 5 0.0008
645 MYOCARDIAL ISCHAEMIA 9 0.0008
646 RENAL IMPAIRMENT 66 0.0008
647 MYOCARDITIS 9 0.0008
648 LEUKOCYTOSIS 14 0.0008
649 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6 0.0008
650 BRONCHOSPASM 11 0.0008
651 RENAL FAILURE 102 0.0008
652 PLATELET COUNT INCREASED 10 0.0008
653 ANAPHYLACTIC REACTION 42 0.0008
654 GRAND MAL CONVULSION 7 0.0008
655 TRICUSPID VALVE INCOMPETENCE 6 0.0008
656 BLOOD CREATININE INCREASED 49 0.0007
657 HAEMATEMESIS 19 0.0007
658 APPENDICITIS 7 0.0007
659 THYROID CANCER 9 0.0007
660 HYPOCALCAEMIA 14 0.0007
661 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
662 TACHYPNOEA 10 0.0007
663 APHASIA 22 0.0007
664 GENERALISED OEDEMA 9 0.0007
665 ECZEMA 38 0.0007
666 ABORTION SPONTANEOUS 29 0.0007
667 MALNUTRITION 8 0.0007
668 ASCITES 21 0.0007
669 PLATELET COUNT DECREASED 75 0.0007
670 ANOREXIA 9 0.0007
671 SKIN DISORDER 23 0.0007
672 SPEECH DISORDER 36 0.0007
673 ACUTE KIDNEY INJURY 105 0.0007
674 NIGHT SWEATS 22 0.0007
675 HYPERBILIRUBINAEMIA 7 0.0007
676 THROMBOSIS 54 0.0007
677 CARDIAC ARREST 55 0.0007
678 INTENTIONAL PRODUCT USE ISSUE 58 0.0007
679 CORONARY ARTERY OCCLUSION 9 0.0007
680 PULMONARY OEDEMA 29 0.0006
681 CONGENITAL ANOMALY 5 0.0006
682 HAIR COLOUR CHANGES 8 0.0006
683 BASAL CELL CARCINOMA 10 0.0006
684 SQUAMOUS CELL CARCINOMA 6 0.0006
685 DYSPNOEA EXERTIONAL 24 0.0006
686 MELAENA 14 0.0006
687 SINUS TACHYCARDIA 9 0.0006
688 ARRHYTHMIA 30 0.0006
689 DRUG INTOLERANCE 61 0.0006
690 VENTRICULAR FIBRILLATION 7 0.0006
691 RECTAL HAEMORRHAGE 27 0.0006
692 THERAPY NON-RESPONDER 28 0.0006
693 INFUSION SITE PAIN 8 0.0006
694 STATUS EPILEPTICUS 7 0.0006
695 MYASTHENIA GRAVIS 5 0.0006
696 CEREBRAL HAEMORRHAGE 22 0.0006
697 NEOPLASM MALIGNANT 41 0.0006
698 DRUG INTERACTION 97 0.0006
699 SLEEP DISORDER 43 0.0006
700 ELECTROLYTE IMBALANCE 7 0.0006
701 LIVE BIRTH 5 0.0006
702 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
703 HAEMODIALYSIS 5 0.0006
704 ANGINA PECTORIS 17 0.0006
705 LIVER DISORDER 26 0.0006
706 INITIAL INSOMNIA 6 0.0006
707 COUGH 163 0.0006
708 PROTEINURIA 11 0.0006
709 ADRENAL INSUFFICIENCY 7 0.0006
710 HYPERGLYCAEMIA 21 0.0006
711 ORTHOSTATIC HYPOTENSION 10 0.0006
712 CHOLESTASIS 11 0.0006
713 SKIN REACTION 8 0.0006
714 DRUG ERUPTION 10 0.0006
715 HYPOTENSION 113 0.0006
716 BREAST CANCER METASTATIC 6 0.0006
717 DYSARTHRIA 21 0.0006
718 GASTROENTERITIS 8 0.0005
719 WHITE BLOOD CELL COUNT INCREASED 21 0.0005
720 VENTRICULAR TACHYCARDIA 9 0.0005
721 NERVOUS SYSTEM DISORDER 17 0.0005
722 BRAIN NEOPLASM 5 0.0005
723 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
724 CONVULSION 31 0.0005
725 IRON DEFICIENCY ANAEMIA 5 0.0005
726 MENTAL STATUS CHANGES 15 0.0005
727 ERYTHEMA MULTIFORME 5 0.0005
728 PRESYNCOPE 13 0.0005
729 FACE OEDEMA 9 0.0005
730 IMMUNE SYSTEM DISORDER 7 0.0005
731 BACK PAIN 123 0.0005
732 MOUTH ULCERATION 11 0.0005
733 FEAR 14 0.0005
734 JAUNDICE 14 0.0005
735 THYROID DISORDER 8 0.0005
736 OXYGEN SATURATION DECREASED 29 0.0005
737 CELLULITIS 26 0.0005
738 RETCHING 11 0.0005
739 SKIN LESION 14 0.0005
740 DYSPNOEA 288 0.0005
741 MYOCLONUS 6 0.0005
742 HYPERLIPIDAEMIA 6 0.0005
743 EMPHYSEMA 5 0.0005
744 CONTRAINDICATED PRODUCT ADMINISTERED 15 0.0005
745 STEVENS-JOHNSON SYNDROME 11 0.0005
746 HYPOAESTHESIA 74 0.0005
747 MOTOR DYSFUNCTION 5 0.0005
748 HYPERCALCAEMIA 6 0.0005
749 PERITONITIS 10 0.0005
750 LIVER FUNCTION TEST ABNORMAL 14 0.0005
751 PETECHIAE 5 0.0005
752 FOLLICULITIS 5 0.0005
753 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
754 PSYCHOTIC DISORDER 14 0.0005
755 HYPERHIDROSIS 61 0.0005
756 CARDIOVASCULAR DISORDER 12 0.0005
757 ALANINE AMINOTRANSFERASE INCREASED 29 0.0005
758 HAEMORRHAGE INTRACRANIAL 7 0.0005
759 NAUSEA 370 0.0005
760 EAR PAIN 9 0.0005
761 NODULE 6 0.0005
762 EPILEPSY 14 0.0005
763 IMPAIRED HEALING 15 0.0005
764 METASTASES TO LIVER 8 0.0005
765 LOSS OF CONSCIOUSNESS 58 0.0005
766 VISUAL ACUITY REDUCED 15 0.0005
767 RENAL DISORDER 21 0.0005
768 HAEMOGLOBIN DECREASED 46 0.0004
769 DRUG EFFECT INCOMPLETE 16 0.0004
770 VAGINAL HAEMORRHAGE 19 0.0004
771 MYOCARDIAL INFARCTION 76 0.0004
772 SHOCK 10 0.0004
773 DYSURIA 16 0.0004
774 DRUG ABUSE 36 0.0004
775 CONJUNCTIVITIS 8 0.0004
776 HAEMOPTYSIS 12 0.0004
777 COORDINATION ABNORMAL 6 0.0004
778 HEPATITIS 11 0.0004
779 BLOOD TEST ABNORMAL 6 0.0004
780 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
781 OEDEMA 23 0.0004
782 MYALGIA 72 0.0004
783 COVID-19 PNEUMONIA 5 0.0004
784 URINARY RETENTION 14 0.0004
785 GASTRITIS 11 0.0004
786 POST PROCEDURAL COMPLICATION 8 0.0004
787 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
788 HEPATITIS C 5 0.0004
789 OSTEOPOROSIS 17 0.0004
790 NEURALGIA 10 0.0004
791 ATRIAL FIBRILLATION 40 0.0004
792 OEDEMA PERIPHERAL 50 0.0004
793 ORAL HERPES 8 0.0004
794 CARDIOMEGALY 5 0.0004
795 HAEMATOCRIT DECREASED 8 0.0004
796 COLON CANCER 6 0.0004
797 CHEST PAIN 73 0.0004
798 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 28 0.0004
799 SYNCOPE 39 0.0004
800 LUNG NEOPLASM MALIGNANT 16 0.0004
801 ANAPHYLACTIC SHOCK 10 0.0004
802 DRUG INEFFECTIVE 510 0.0004
803 DEVICE MALFUNCTION 27 0.0004
804 ABDOMINAL PAIN 89 0.0004
805 ALOPECIA 75 0.0004
806 DECREASED APPETITE 88 0.0004
807 ULCER 6 0.0004
808 DYSPHONIA 22 0.0004
809 METABOLIC ACIDOSIS 12 0.0004
810 EYE HAEMORRHAGE 5 0.0004
811 CARDIAC FAILURE CONGESTIVE 30 0.0004
812 CONDITION AGGRAVATED 113 0.0004
813 DEHYDRATION 49 0.0004
814 METASTASES TO BONE 6 0.0004
815 DRUG LEVEL INCREASED 6 0.0004
816 PRODUCT USE ISSUE 68 0.0004
817 CARDIO-RESPIRATORY ARREST 15 0.0004
818 PARAESTHESIA 56 0.0004
819 PREGNANCY 7 0.0003
820 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
821 THERAPEUTIC RESPONSE DECREASED 21 0.0003
822 RESPIRATORY TRACT INFECTION 9 0.0003
823 HAEMORRHAGE 36 0.0003
824 COGNITIVE DISORDER 16 0.0003
825 LYMPHOCYTE COUNT DECREASED 6 0.0003
826 BLISTER 19 0.0003
827 COMA 16 0.0003
828 LIVER FUNCTION TEST INCREASED 7 0.0003
829 HYPOACUSIS 14 0.0003
830 PHARYNGEAL OEDEMA 5 0.0003
831 MUSCULOSKELETAL PAIN 17 0.0003
832 MUSCULOSKELETAL CHEST PAIN 5 0.0003
833 CONSTIPATION 70 0.0003
834 INFUSION RELATED REACTION 21 0.0003
835 ERYTHEMA 65 0.0003
836 ABSCESS 5 0.0003
837 HYPOPHAGIA 8 0.0003
838 ORAL PAIN 7 0.0003
839 ERECTILE DYSFUNCTION 8 0.0003
840 SKIN ULCER 8 0.0003
841 LOWER RESPIRATORY TRACT INFECTION 14 0.0003
842 URINARY TRACT INFECTION 52 0.0003
843 RENAL INJURY 9 0.0003
844 CHEST DISCOMFORT 31 0.0003
845 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
846 BLOOD UREA INCREASED 5 0.0003
847 HYPERTENSION 63 0.0003
848 THROAT TIGHTNESS 8 0.0003
849 HEPATIC FUNCTION ABNORMAL 11 0.0003
850 PALLOR 8 0.0003
851 FATIGUE 228 0.0003
852 GASTROINTESTINAL DISORDER 26 0.0003
853 HYPERSENSITIVITY 53 0.0003
854 COLD SWEAT 5 0.0003
855 TREMOR 47 0.0003
856 BRADYCARDIA 15 0.0003
857 CYSTITIS 9 0.0003
858 RED BLOOD CELL COUNT DECREASED 8 0.0003
859 CEREBROVASCULAR ACCIDENT 47 0.0003
860 FEELING HOT 17 0.0003
861 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
862 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
863 RASH MACULO-PAPULAR 6 0.0003
864 RASH PAPULAR 6 0.0003
865 ASTHENIA 100 0.0003
866 DEATH 226 0.0003
867 SKIN DISCOLOURATION 12 0.0003
868 OROPHARYNGEAL PAIN 24 0.0003
869 RASH PRURITIC 14 0.0003
870 PALPITATIONS 30 0.0003
871 CONFUSIONAL STATE 40 0.0002
872 LACTIC ACIDOSIS 8 0.0002
873 DIARRHOEA 156 0.0002
874 PNEUMONIA ASPIRATION 6 0.0002
875 PAIN IN EXTREMITY 70 0.0002
876 LABORATORY TEST ABNORMAL 7 0.0002
877 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
878 CARDIAC DISORDER 22 0.0002
879 SEIZURE 27 0.0002
880 HAEMATURIA 8 0.0002
881 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
882 HEADACHE 145 0.0002
883 MENTAL DISORDER 10 0.0002
884 PRODUCT PRESCRIBING ISSUE 5 0.0002
885 ARTHRALGIA 95 0.0002
886 DRUG ADMINISTRATION ERROR 7 0.0002
887 DISORIENTATION 9 0.0002
888 MUSCULAR WEAKNESS 25 0.0002
889 FALL 72 0.0002
890 BREAST CANCER 20 0.0002
891 PAIN IN JAW 6 0.0002
892 DIABETES MELLITUS 16 0.0002
893 FIBROMYALGIA 5 0.0002
894 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
895 AGITATION 15 0.0002
896 WEIGHT DECREASED 57 0.0002
897 SOMNOLENCE 41 0.0002
898 ARTHRITIS 16 0.0002
899 ABNORMAL BEHAVIOUR 8 0.0002
900 EXTRAPYRAMIDAL DISORDER 5 0.0002
901 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
902 ABDOMINAL DISTENSION 21 0.0002
903 BLOOD POTASSIUM DECREASED 6 0.0002
904 MEDICATION ERROR 11 0.0002
905 ABDOMINAL PAIN LOWER 5 0.0002
906 GASTRIC CANCER 5 0.0002
907 ADVERSE EVENT 18 0.0002
908 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
909 COVID-19 34 0.0002
910 DYSPEPSIA 19 0.0002
911 HEART RATE INCREASED 19 0.0002
912 HEPATIC ENZYME INCREASED 13 0.0002
913 PANCREATITIS 10 0.0002
914 PRODUCTIVE COUGH 9 0.0002
915 RASH ERYTHEMATOUS 9 0.0002
916 EPISTAXIS 14 0.0002
917 MALAISE 80 0.0002
918 DRY EYE 9 0.0002
919 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
920 DIZZINESS 88 0.0002
921 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
922 EMOTIONAL DISTRESS 21 0.0002
923 DELIRIUM 6 0.0002
924 FLUSHING 17 0.0002
925 URTICARIA 28 0.0002
926 DISTURBANCE IN ATTENTION 9 0.0002
927 ABDOMINAL PAIN UPPER 34 0.0002
928 TREATMENT NONCOMPLIANCE 9 0.0002
929 PLASMA CELL MYELOMA 6 0.0002
930 SWELLING FACE 10 0.0002
931 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
932 BRONCHITIS 11 0.0001
933 PAIN 91 0.0001
934 OCULAR HYPERAEMIA 7 0.0001
935 HYPOGLYCAEMIA 7 0.0001
936 INFLUENZA 16 0.0001
937 ROAD TRAFFIC ACCIDENT 6 0.0001
938 LETHARGY 8 0.0001
939 GAIT DISTURBANCE 26 0.0001
940 ANGIOEDEMA 6 0.0001
941 WHEEZING 8 0.0001
942 THROAT IRRITATION 6 0.0001
943 RASH 57 0.0001
944 MOBILITY DECREASED 9 0.0001
945 NECK PAIN 7 0.0001
946 AMNESIA 8 0.0001
947 PRURITUS 46 0.0001
948 FLUID RETENTION 6 0.0001
949 DRUG EFFECT DECREASED 6 0.0001
950 SWELLING 10 0.0001
951 UNEVALUABLE EVENT 8 0.0001
952 RENAL CANCER 5 0.0001
953 VISION BLURRED 14 0.0001
954 MEMORY IMPAIRMENT 14 0.0001
955 VERTIGO 6 0.0001
956 DISCOMFORT 6 0.0001
957 MUSCULOSKELETAL STIFFNESS 8 0.0001
958 MUSCLE SPASMS 16 0.0001
959 BURNING SENSATION 6 0.0001
960 NASAL CONGESTION 5 0.0001
961 INFLUENZA LIKE ILLNESS 7 0.0001
962 MIGRAINE 8 0.0001
963 SINUSITIS 8 0.0001
964 ADVERSE DRUG REACTION 7 0.0001
965 CONTUSION 7 0.0001
966 VISUAL IMPAIRMENT 9 0.0001
967 PERIPHERAL SWELLING 11 0.0001
968 SKIN EXFOLIATION 6 0.0001
969 DYSGEUSIA 5 0.0001
970 WEIGHT INCREASED 15 0.0001
971 JOINT SWELLING 8 0.0001
972 DEPRESSION 15 0.0001
973 NASOPHARYNGITIS 12 0.0001
974 INSOMNIA 17 0.0001
975 ABDOMINAL DISCOMFORT 10 0.0001
976 FEELING ABNORMAL 14 0.0001
977 ANXIETY 16 0.0001
978 NO ADVERSE EVENT 10 0.0001
979 ASTHMA 6 0.0001
980 BLOOD PRESSURE INCREASED 8 0.0001
981 PRODUCT QUALITY ISSUE 7 0.0001
982 BLOOD GLUCOSE INCREASED 9 0.0000
983 OVERDOSE 10 0.0000
984 HOSPITALISATION 6 0.0000